Researchers are experimenting with memory-based activities as a way to treat Alzheimer's, saying it can boost cognitive ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

One London clinic has become the first in Europe to offer the drug privately for an 'eye-watering' annual sum, after the NHS ...

Fact checked by Nick Blackmer By 2060, nearly 14 million Americans may be living with Alzheimer’s disease. We still don’t ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

We examined the association between vulnerability to financial exploitation and thickness of a brain region called the ...

Widely prescribed and moderately helpful in improving cognition, the drugs are not thought to slow the underlying neurodegenerative process, as is the hope for newer Alzheimer’s treatments that ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Researchers have found that a widely used anesthesia gas can help lower the progression of Alzheimer's disease.